Antimicrobial susceptibility testing

MICRONAUT-S Pneumococci & Haemophilus MIC

MIC values for 14 different antibiotics and antibiotic combinations commonly used for treatment of infections caused by Streptococcus pneumoniae and Haemophilus influenzae

MIC determination of fourteen antibiotics commonly used for treatment of infections caused by pneumococci and Haemophilus influenzae

In recent years, increasing antimicrobial resistance rates in pneumococci and Haemophilus influenzae have been observed. This had an impact on treatment of both hospital and community acquired infections. Therefore, accurate and reliable MIC determination is crucial for successful antimicrobial therapy.

 

The routine MIC plate MICRONAUT-S Pneumococcus & Haemophilus MIC provides a wide range of antibiotics commonly used for the treatment of infections caused by pneumococci and Haemophilus influenzae. It enables phenotypic quantification of MIC values for 14 antibiotics in a single test run. Obtained MIC values can be interpreted according to currently valid EUCAST or CLSI standards.

MIC plate for AST of Streptococcus pneumoniae and Haemophilus influenzae

The MICRONAUT-S Pneumococcus & Haemophilus MIC test plate offers a range of features and benefits relating to the phenotypic quantification of MIC values for important routine antibiotics commonly used for treatment of bacterial infections caused by pneumococci and Haemophilus influenzae.

  • AST is carried out by broth microdilution method
  • Resistance determination of Streptococcus pneumoniae and Haemophilus influenzae against antibiotics and antibiotic combinations
  • AST of fourteen important antibiotics and antibiotic combinations in a single test run
  • Analysis and interpretation of MIC values after visual or automated reading according to EUCAST or CLSI standards

 

Susceptibility testing of pneumococci

  • Penicillin G MIC determination
  • Detection of cephalosporin resistance (ceftriaxone, cefuroxime)
  • Detection of carbapenem resistance (meropenem, imipenem)
  • Detection of macrolide resistance (erythromycin, clarithromycin)
  • Detection of vancomycin resistance
  • Detection of quinolone resistance (moxifloxacin, detection of group IV quinolone resistance)
  • MIC determination of rifampicin, clindamycin and doxycycline

Susceptibility testing of Haemophilus influenzae

  • Detection of resistance to aminopenicillin (ampicillin), cephalosporins (ceftriaxone, cefuroxime), ß-lactam inhibitor combinations (amoxicillin-clavulanic acid) and carbapenems (imipenem, meropenem)
  • Detection of macrolide resistance (erythromycin, clarithromycin)
  • Detection of quinolone resistance (moxifloxacin, ciprofloxacin)
  • MIC determination of rifampicin and doxycycline

 

Please contact your local representative for availability in your country.

Not for sale in the USA. MERLIN Gesellschaft für mikrobiologische Diagnostika mbH – A Bruker Company (www.merlin-diagnostika.de)